Showing results (11-20 of 31) with videos related to
Sort By:
Pageof 4
Experimental Hematology|December 23, 2008
Quantitative monitoring of NPM1 mutations provides a valid minimal residual disease parameter following allogeneic stem cell transplantationUlrike Bacher, Anita Badbaran, Boris Fehse, et al.Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|September 12, 2009
Current status and perspectives of tyrosine kinase inhibitor treatment in the posttransplant period in patients with chronic myelogenous leukemia (CML)Evgeny Klyuchnikov, Nicolaus Kröger, Tim H Brummendorf, et al.Paediatric Anaesthesia|May 19, 2022
The impact of modified fluid gelatin 4% in a balanced electrolyte solution on plasma osmolality in children-A noninterventional observational studyDaniel Rudolf, Lars Witt, Dietmar Boethig, et al.Advances in Hematology|October 29, 2010
The Role of Allogeneic Stem Cell Transplantation in Relapsed/Refractory Hodgkin's Lymphoma PatientsEvgeny Klyuchnikov, Ulrike Bacher, Nicolaus Kröger, et al.Advances in Hematology|November 24, 2011
Molecular diagnostics, targeted therapy, and the indication for allogeneic stem cell transplantation in acute lymphoblastic leukemiaAnthony Oyekunle, Torsten Haferlach, Nicolaus Kröger, et al.Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 8, 2010
Diagnostic tools in the indications for allogeneic stem cell transplantation in myelodysplastic syndromesUlrike Bacher, Claudia Haferlach, Nicolaus Kröger, et al.Intensive Care Medicine|October 20, 2012
Evaluation of 36 formulas for calculating plasma osmolalityAndreas S Fazekas, Georg-Christian Funk, Daniela S Klobassa, et al.Resuscitation|December 8, 2006
Use of an inspiratory impedance threshold valve during chest compressions without assisted ventilation may result in hypoxaemiaHolger Herff, Claus Raedler, Rolf Zander, et al.Clinical and Experimental Medicine|July 25, 2009
Bone marrow mesenchymal stromal cells remain of recipient origin after allogeneic SCT and do not harbor the JAK2V617F mutation in patients with myelofibrosisUlrike Bacher, Svetlana Asenova, Anita Badbaran, et al.Resuscitation|December 9, 2008
Accurate and continuous measurement of oxygen deficit during haemorrhage in pigsJan P Roesner, Alexander Koch, Richard Bateman, et al.Pageof 4